Ligand · A4I
A4I · (1R,2R,4S)-4-{(2R)-2-[(3S,6R,7E,9R,10R,12R,14S,15E,17E, 19e,21s,23s,26r,27r,30s,34as)-9,27-dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26, 27,28,29,31,32,33,34,34A-tetracosahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontin-3-yl]propyl}-2-methoxycyclohexyl 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate
A4I, (1R,2R,4S)-4-{(2R)-2-[(3S,6R,7E,9R,10R,12R,14S,15E,17E, 19e,21s,23s,26r,27r,30s,34as)-9,27-dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26…
- Component
- A4I
- Formula
- C56 H87 N O16
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
A4I in 2 structures; the first of them:
- 7SQ9 · Cryo-EM structure of mouse temsirolimus/PI(3,5)P2-bound TRPML1 channel at 2.11 Angstrom… · A4I A602 · binds LEU418, LEU422, VAL425, MET426, CYS429, VAL432, ALA433, TYR436 and 14 more
- 7SQ9 · Cryo-EM structure of mouse TEMSIROLIMUS/PI(3,5)P2-bound TRPML1 channel at 2.11 ångström… · A4I A602 · binds LEU422, VAL425, MET426, CYS429, VAL432, ALA433, TYR436, LEU437 and 9 more
Residues it binds most
LEU 8, SER 8, TYR 8, VAL 8, MET 8, PHE 8, CYS 8, ALA 8 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.